Onconova Therapeutics Inc (ONTX)

Onconova Therapeutics Inc Aktie (ONTX) Neueste Nachrichten

Who Are The Top Investors In Onconova Therapeutics Inc (NASDAQ:ONTX)? - Yahoo New Zealand News

Yahoo New Zealand News

'Best-In-Class Virology And Oncology': Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to ... - Orrick

Orrick

Onconova Therapeutics' Strategic Acquisition and Corporate Transformation - TipRanks.com - TipRanks

TipRanks

Onconova, Trawsfynydd Therapeutics announces business combination - TipRanks.com - TipRanks

TipRanks

Traws Pharma Announces New Employee Inducement Grants

GlobeNewswire Inc.

Onconova and Trawsfynydd merge to form Traws Pharma - Investing.com South Africa

Investing.com South Africa

We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate - Simply Wall St

Simply Wall St

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024

GlobeNewswire Inc.

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Benzinga

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Benzinga

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

InvestorPlace

Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s

GlobeNewswire Inc.

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

GlobeNewswire Inc.

US-based firm appoints Zimbabwean Dr as Chief Medical Officer - The Zimbabwe Mail

The Zimbabwe Mail

Onconova doses first patient in trial of cancer combo therapy - Clinical Trials Arena

Clinical Trials Arena

3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% - Penny Stocks

Penny Stocks

Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue? - AOL

AOL

Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz

citybiz

Onconova Therapeutics Inc (NASDAQ:ONTX) Doses The First Patient In Phase 2 Clinical Trial At the EB House Austria ... - BP Journal

BP Journal

PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - The Philadelphia Inquirer

The Philadelphia Inquirer

45 Stocks Moving in Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Arbutus Biopharma - Benzinga

Benzinga

Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In China In Collaborations With ... - BP Journal

BP Journal

Onconova Therapeutics Inc (NASDAQ:ONTX) says the Pivotal Phase 3 INSPIRE trial did not meet its Primary Endpoint - BP Journal

BP Journal

Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire Phase 3 Trial Soon: Plans ... - BP Journal

BP Journal

Onconova Therapeutics Inc. (NASDAQ:ONTX) Publishes Phase 1 Oral Rigosertib Combination With Azacitidine Study ... - BP Journal

BP Journal

Onconova Therapeutics Announces $16.5M Share Purchase - GlobeNewswire

GlobeNewswire

People in the News - The Philadelphia Inquirer

The Philadelphia Inquirer